Aptose Biosciences Inc.
(Toronto Stock Exchange : APTO)

( )
APTO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.37%86.271.3%$1274.24m
AMGNAmgen Inc.
0.97%203.881.2%$676.03m
GILDGilead Sciences, Inc.
0.77%69.180.9%$577.80m
LOXOLoxo Oncology Inc
0.11%233.5012.7%$474.39m
BIIBBiogen Inc.
-0.27%337.421.3%$459.87m
ILMNIllumina, Inc.
0.87%312.753.5%$351.51m
VRTXVertex Pharmaceuticals Incorporated
2.19%194.701.9%$332.94m
REGNRegeneron Pharmaceuticals, Inc.
0.35%418.842.6%$322.26m
ALXNAlexion Pharmaceuticals, Inc.
2.12%117.052.0%$239.80m
TSROTESARO, Inc.
0.03%74.9614.4%$196.22m
AAgilent Technologies, Inc.
2.10%72.311.5%$166.45m
EXASExact Sciences Corporation
4.19%78.8025.3%$156.07m
INCYIncyte Corporation
-0.32%78.422.5%$153.20m
SRPTSarepta Therapeutics, Inc.
1.22%122.8015.4%$142.40m
LGNDLigand Pharmaceuticals Incorporated
6.49%117.9023.1%$123.00m

Company Profile

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG'806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.